BENF revenueQ1 2027$15.88M
BENF revenue was $15.88M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$12.62M a year earlier. For the full fiscal 2026 it was -$39.13M, compared with -$6.50M in fiscal 2025.
Beneficient (BENF) financials
For the twelve months ended Jun 30, 2026, Beneficient reported -$10.63M of revenue and -$29.13M of net income.
- Revenue, TTM
- -$10.63M
- Net income, TTM
- -$29.13M
- Free cash flow, TTM
- -$31.99M
- Cash
- $5.58M
- Market cap
- $12.8M
FY2020FY2026
FY2020FY2026
FY2020FY2026
BENF revenue and earnings growth
BENF net incomeQ1 2027-$6.78M
BENF net income was -$6.78M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$65.08M a year earlier. For the full fiscal 2026 it was -$87.43M, compared with $51.16M in fiscal 2025.
BENF free cash flowQ1 2027-$4.11M
BENF free cash flow was -$4.11M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$10.93M a year earlier. For the full fiscal 2026 it was -$38.81M, compared with -$38.80M in fiscal 2025.
Income statement
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | -$39.13M | -$6.50M | $4.79M | -$54.01M | $55.31M | $140.33M |
| Operating income | -$166.51M | -$24.18M | -$2.65B | -$253.17M | -$71.12M | -$47.41M |
| Interest expense | - | - | $17.56M | $15.47M | $27.46M | $32.55M |
| Pre-tax income | -$164.52M | -$723.0K | -$2.66B | -$253.17M | -$105.13M | -$47.41M |
| Income tax | $214.0K | $80.0K | $788.0K | -$1.07M | $0 | $3.46M |
| Net income | -$87.43M | $51.16M | -$2.10B | -$130.98M | -$63.01M | -$58.04M |
| EPS, basic | - | - | - | -$1.94 | -$1.84 | -$1.27 |
| EPS, diluted | - | - | - | -$1.94 | -$1.84 | -$1.27 |
| Diluted shares | - | - | - | 67.5M | 51.5M | 45.8M |
Balance sheet
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $2.54M | $1.35M | $7.98M | $9.54M | $20.32M | $17.88M |
| Goodwill | $9.91M | $9.91M | $13.61M | $2.37B | $2.37B | $2.37B |
| Total assets | $238.77M | $354.88M | $368.50M | $2.91B | - | - |
| Total liabilities | $337.53M | $299.27M | $309.57M | $231.79M | - | - |
| Shareholders' equity | -$189.29M | -$34.92M | -$192.12M | $1.73B | $1.09B | $986.35M |
Cash flow
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$38.72M | -$37.70M | -$58.22M | -$95.12M | -$57.00M | -$54.01M |
| Capital expenditures | $96.0K | $1.10M | $1.76M | $2.08M | $4.20M | $3.22M |
| Free cash flow | -$38.81M | -$38.80M | -$59.98M | -$97.19M | -$61.21M | -$57.23M |
| Investing cash flow | $61.21M | $28.11M | $44.06M | $63.02M | $44.59M | -$5.98M |
| Financing cash flow | -$21.29M | $2.97M | $12.59M | -$34.46M | $14.86M | $43.86M |
| Stock-based compensation | $1.63M | $5.65M | $39.10M | $10.09M | $23.15M | $107.81M |
| Depreciation and amortization | $746.0K | $1.70M | $3.77M | $3.61M | $1.99M | $1.05M |
Key ratios
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | -235.7% | - | - | -60.6% | - |
| Operating margin | - | - | -55281.7% | - | -128.6% | -33.8% |
| Net margin | - | - | -43741.2% | - | -113.9% | -41.4% |
| Free cash flow margin | - | - | -1251.8% | - | -110.7% | -40.8% |
| Return on equity | - | - | - | -7.6% | -5.8% | -5.9% |
| Return on assets | -36.6% | 14.4% | -568.7% | -4.5% | - | - |
Income statement
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.88M | -$42.41M | $18.67M | -$2.76M | -$12.62M | - | $4.74M | $8.56M | $11.03M | -$3.14M | $7.45M | -$13.0K |
| Operating income | -$377.0K | -$59.94M | $3.94M | -$17.86M | -$92.65M | -$45.30M | -$9.51M | -$13.71M | $44.34M | -$194.86M | -$915.95M | -$381.76M |
| Interest expense | - | - | - | - | - | - | - | - | - | $3.99M | $4.67M | $5.11M |
| Pre-tax income | - | -$59.94M | $5.94M | -$17.86M | -$92.65M | -$45.30M | -$9.51M | $9.75M | $44.34M | -$194.86M | -$924.80M | -$381.76M |
| Income tax | $0 | $171.0K | $0 | $43.0K | $0 | -$661.0K | $713.0K | $0 | $28.0K | $713.0K | $75.0K | $0 |
| Net income | -$6.78M | -$38.63M | $19.91M | -$3.63M | -$65.08M | -$780.0K | -$8.64M | $12.91M | $47.67M | -$66.22M | -$542.17M | -$371.74M |
Balance sheet
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $5.58M | $2.54M | $7.87M | $4.90M | $7.61M | $1.35M | $4.20M | $4.80M | $4.71M | $7.98M | $11.27M | $2.41M |
| Goodwill | $9.91M | $9.91M | $9.91M | $9.91M | $9.91M | $9.91M | $9.91M | $9.91M | $10.21M | $13.61M | $81.71M | $964.94M |
| Total assets | $250.94M | $238.77M | $337.86M | $316.23M | $334.51M | $354.88M | $400.01M | $368.79M | $361.30M | $368.50M | $500.56M | $1.46B |
| Total liabilities | $344.50M | $337.53M | $375.90M | $368.53M | $364.38M | $299.27M | $295.23M | $256.45M | $258.54M | $309.57M | $245.54M | $273.69M |
| Shareholders' equity | -$184.09M | -$189.29M | -$128.57M | -$142.83M | -$120.40M | -$34.92M | $14.26M | -$13.19M | -$148.29M | -$192.12M | $3.97M | $932.26M |
Cash flow
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.11M | -$3.98M | -$9.37M | -$14.53M | -$10.84M | -$8.45M | -$10.00M | -$8.61M | -$10.65M | -$8.65M | -$22.21M | -$13.45M |
| Capital expenditures | $0 | $0 | $0 | $0 | $96.0K | $124.0K | $42.0K | $269.0K | $664.0K | $429.0K | $375.0K | $432.0K |
| Free cash flow | -$4.11M | -$3.98M | -$9.37M | -$14.53M | -$10.93M | -$8.57M | -$10.04M | -$8.88M | -$11.31M | -$9.07M | -$22.59M | -$13.88M |
| Investing cash flow | $6.91M | $1.96M | $16.42M | $16.37M | $26.45M | $10.72M | $6.22M | $4.77M | $6.39M | $7.32M | $11.00M | $14.51M |
| Financing cash flow | $233.0K | -$3.30M | -$4.08M | -$4.55M | -$9.35M | -$5.13M | $3.18M | $3.92M | $991.0K | -$1.97M | $20.07M | -$2.53M |
| Stock-based compensation | $185.0K | $339.0K | $367.0K | $462.0K | $461.0K | $487.0K | $804.0K | $3.36M | $994.0K | $1.57M | $2.03M | $8.50M |
| Depreciation and amortization | $125.0K | $220.0K | $141.0K | $143.0K | $242.0K | $443.0K | $447.0K | $391.0K | $414.0K | $742.0K | $1.11M | $991.0K |
Key ratios
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | - | 293.7% | -132.3% | -214.5% | - | -36.3% | - | 2105.6% | - | -35.1% | - |
| Operating margin | -2.4% | - | 21.1% | - | - | - | -200.6% | -160.2% | 402.0% | - | -12297.9% | - |
| Net margin | -42.7% | - | 106.7% | - | - | - | -182.2% | 150.8% | 432.2% | - | -7279.4% | - |
| Free cash flow margin | -25.9% | - | -50.2% | - | - | - | -211.7% | -103.7% | -102.6% | - | -303.3% | - |
Source: XBRL data Beneficient files with the SEC, latest filing dated Aug 14, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
BENF peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| BENF | -$10.63M | - | -$29.13M | - | $12.8M |
| AXP | $77.59B | +10.2% | $12.26B | 15.8% | $217.47B |
| SPGI | $17.21B | +18.2% | $4.99B | 29.0% | $136.57B |
| MCO | $8.18B | +9.0% | $2.88B | 35.3% | $88.11B |
| NU | $15.77B | +37.0% | $2.87B | 18.2% | $60.02B |
| RKT | $11.46B | +90.4% | $1.30B | 11.4% | $43.11B |
| COIN | $5.63B | -26.6% | -$701.62M | -12.5% | $36.03B |
| AFRM | $4.59B | +32.7% | $2.01B | 43.9% | $23.06B |
| SYF | $19.31B | +2.6% | $3.33B | 17.3% | $22.80B |
BENF FAQ
6 questionsWhat is BENF revenue?
Beneficient (BENF) reported -$10.63M of revenue for the twelve months ended Jun 30, 2026. Revenue for fiscal 2026 was -$39.13M.Is BENF profitable?
No. Beneficient reported a net loss of $29.13M for the twelve months ended Jun 30, 2026.How much cash and debt does BENF have?
Beneficient reported $5.58M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is BENF free cash flow?
Beneficient generated -$31.99M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$31.99M less capital expenditures.When did BENF last report financial results?
The latest statements here come from Beneficient's 10-Q filed on Aug 14, 2026, covering the period ended Jun 30, 2026.Where does this BENF financial data come from?
Quantisnow builds these statements from the structured XBRL data Beneficient files with the SEC. It is provided for information only and is not investment advice.